SCHOTT MINIFAB Brief
Your partner in advancing diagnostics and life sciences.
SCHOTT MINIFAB provides integrated services for contract design, development and manufacturing of diagnostic and life science consumables - innovation to help you introduce new discoveries, enable precise health care treatments and improve patients outcomes.
Nine Critical Factors to Diagnostic Microarray Development. 20 Years of Lessons Learned.
The successful design and development of medical diagnostic point of care or clinical microarrays can be among the most daunting of challenges for both startups and incumbent companies alike. Navigating this challenging path requires significant experience and multidisciplinary expertise. With an introduction from SCHOTT MINIFAB’s Dr. James Downs, in this 30-minute presentation, Dr. Tamma Kaysser-Kranich will discuss 9 key factors critical to diagnostic microarray development for the IVD market.
The webinar had some buffering issues effecting the audio capture. Click here for a pre-recorded session.
SCHOTT Opens First Facility in U.S. to Increase Capabilities and Capacity for Development and Manufacturing of Diagnostics and Life Sciences Products
TUESDAY, JANUARY 10, 2023, PHOENIX, AZ, USA
- Multi-million-dollar investment sets up new facility in Phoenix, AZ, that will focus on production of custom DNA and protein biosensors and other microarrays on glass, semiconductors, and polymer microfluidic consumable devices SCHOTT MINIFAB offers complete set of solutions for contract design and manufacturing of rapid diagnostic devices to enable precise treatments and therapies.
- New facility adds to the capabilities already in place in Jena, Germany and Melbourne, Australia, enabling SCHOTT MINIFAB to work locally with customers in the major global markets for life science research and advanced diagnostics
- Expansion will create 150 new regional jobs in the Phoenix region over the next few years
Web Seminar Replay: Point-of-care diagnostics design, development and manufacturing. When outsourcing makes sense.
Watch Webinar Replay: Thursday, March 10th 2022 @ 11:00AM AEDT
This webinar will examine these challenges and explore which key decision-making factors are important when considering an in-house effort vs outsourcing to a partner. In this presentation, Andrew Campitelli will address these issues with the goal of helping diagnostic stakeholders make better decisions toward the growth of their diagnostic programs.
New Microarray Development & Manufacture Capabilities: Watch Free Live Session
Recorded: Lab-on-Chip & Microfluidics Congress, Coronado CA
Pre-scored Glass Wafer Lowering the Cost of Biochips
Written by Iris Weinreich
Whether you are developing a glass biochip for inhouse use, or as a commercial product, cost-of-good (COGs) has always been at the top of consideration list. Key to managing COGs is the ability to keep costs as low as possible in small quantities whilst still taking advantage of economy of scale as demand increases. This is particularly challenging with customized glass chips.
More...
Watch Free Web Session: Deep Dive Into Microfluidics Manufacturing and Microarrays
Watch Free Wen Session
LIVE recorded on Wednesday, November 10th 2021
Join leading experts in microfluidic polymer and glass diagnostics for this deep dive into microfluidic diagnostics development. The two sessions blend commercial and technical subjects across IVD manufacturing and microarray development.
Functional 3D-Glass components for fluidic and opto-mechanical applications supported by EFRE
High-precision 3D-glass components for diagnostics
We are happy to announce that the joint project between SCHOTT Technical Glass Solutions GmbH, LensTec Jena GmbH and the Fraunhofer Insitute for Applied Optics and Precision Engineering IOF is receiving support from the European Regional Development Fund.
Expanding diagnostics business: SCHOTT signs agreement to acquire Applied Microarrays Inc.
28 September 2021, Germany, Mainz
- The acquisition of the Arizona-based microarray solutions company extends SCHOTT’s manufacturing presence in the United States and strengthens its bioscience capabilities.
- Customers will benefit from enhanced development and manufacture capabilities including high-density microarray printing.
SCHOTT MINIFAB is exhibiting at JACLaS 2021 - Yokohama 8-10 October
SCHOTT MINIFAB is pleased to be exhibiting again at JACLaS 2021. Click here for more info >
